AzTrials
AzTrials

Spinal Cord InjuriesNCT03680872

Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System

A study testing Bidirectional Neural Bypass System in people with Spinal Cord Injuries and Spinal Cord Injury Cervical, run by Chad Bouton at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia. Read more about this study

Who is it for?
Ages 22 to 65 years
What is being tested?
Bidirectional Neural Bypass System
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteUnited States
Study dates
30 Sep 2019to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Males and females between 22 and 65 years of age
  • Individuals with a stable cervical spinal cord injury that have International Standards for the Neurological Classification of SCI (ISNCSCI) motor scores for fingers of 0 - 2 (non-functional) and ISNCSCI sensory scores of 0 - 2 (not normal) on the palmar side
  • Individuals at least one year from initial spinal cord injury
  • Individuals that are considered English Proficient due to the study requirements to follow verbal commands during testing sessions
  • Individuals that are able to comprehend the study goals and procedures, and are able to provide informed consent for participation.
  • Individuals that are willing and able to visit the study center for study procedures that will be 1-3 sessions a week for up to 48 months at 1-4 hours per session.
  • Have the ability and willingness to undergo upper limb electrodiagnostic and nerve conduction studies
  • Demonstrate typical amplitude, latency, and conduction velocity in the distal median, ulnar, and radial nerves of at least one upper limb

Who cannot join

  • Individuals participating in another research study that may affect the conduct or results of this study
  • Individuals having or exhibiting any of the following:
  • Medical contraindications for diffusion tensor imaging, functional magnetic resonance imaging, electromyography, computed tomography, cortical stimulation, or craniotomies/surgeries
  • Prior difficulties or allergy to general anesthesia
  • Active wound healing or skin breakdown issues
  • Stage III-IV pressure ulcers
Show all 32Show fewer
  • Chronically-implanted electronic medical device (e.g. baclofen pump, deep brain stimulator, epidural stimulator, cardiac pacemaker, vagus nerve stimulator, or other)
  • Prior tendon transfer to enhance hand function
  • History of autoimmune disease
  • Cancer
  • Biochemical abnormalities of the liver, kidney, or pancreas
  • Ventilator dependence
  • History of serious mood or thought disorder
  • Significant residual clinically evident traumatic brain injury or cognitive impairment
  • Uncontrolled autonomic dysreflexia
  • Spasticity in the upper extremities that is uncontrolled by pharmacological methods
  • Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months
  • Individuals with any type of destruction and/or damage to the motor cortex region as determined by fMRI.
  • History of a neurological ablation procedure
  • History of hemorrhagic stroke
  • History of infectious or chronic diseases, such as HIV or tuberculosis
  • Individuals with any of the following co-morbid conditions that would interfere with study activities or response to treatment:
  • Life expectancy < 3 years
  • Severe chronic pulmonary disease
  • Intractable seizure disorders
  • Local, systemic acute or chronic infectious illness
  • Life threatening cardiac arrhythmias
  • Severe collagen vascular disorder
  • Kidney failure or other major organ systems failures
  • Individuals with a substance abuse (alcoholism or other) problem
  • Pregnant women
  • Prisoners

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Erona Ibroci, MPH contact

516-562-3634

eibroci@northwell.edu

United States1 site, 1 recruiting
  • Northwell Health's The Feinstein Institute for Medical Research

    Manhasset, New York, 11030

    Erona Ibroci, MPH, 5165623634, eibroci@northwell.edu

    Chad E Bouton

    Recruiting

Other trials in United States

About this study

This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.

Read the detailed description

This study consists of the following three phases: baseline visit, surgical procedure, and restoration sessions.

At the baseline visit, participants will undergo a medical history review, physical and neurological examination, functional assessment of motor and sensory capabilities, a functional magnetic resonance image (fMRI), diffusion tensor image (DTI), and a transcutaneous neuromuscular and transcutaneous spinal cord stimulation test.

Participants deemed eligible for continued participation will then undergo a craniotomy under anesthetic sedation to implant the investigational device. The surgeon will implant microelectrode arrays into the primary motor cortex to record neural activity associated with desired movements and into the primary somatosensory cortex to deliver stimulation in order to provide sensory perception.

While in surgical recovery, participants will have their vital signs monitored, be provided pain medication and antibiotics, and undergo a computed tomography (CT). The participants may also undergo electromyography and microneurography while in recovery. After being evaluated by a physician, the participants will be discharged from the hospital to continue their recovery.

After fully recovering, participants will attend restoration sessions at the Feinstein Institute for Medical Research's Center for Bioelectronic Medicine. Participants will attend up to 3 study sessions a week for approximately 48 months, with each session lasting up to 4 hours. The sessions will progressively focus on identifying neural activity related to desired movements, restoring volitional control of the hand and wrist, restoring tactile perception, and then restoring volitional control and tactile perception of the hand and wrist simultaneously.

During the sessions, participants will have brain signals recorded from electrodes implanted in the brain, receive transcutaneous electrical stimulation to the arm and/or spinal cord, and receive a small amount of electrical current to the electrodes implanted in the brain. The participants may also undergo electromyography and microneurography during some of the sessions.

The study will be considered complete after completion of enrollment (up to 7 participants), completion of study procedures by all participants, and the completion of analysis of identifiable study data.

Being tested
Bidirectional Neural Bypass System
Keywords
Physical and Rehabilitation Medicine, Biomedical Engineering, Paralysis, Tetraplegia, Quadriplegia, Movement Restoration, Muscle Stimulation, Tactile Sensation, Spinal Cord Stimulation
Medical subject headings
Spinal Cord Injuries, Paralysis, Quadriplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bidirectional Neural Bypass SystemDevice

    These participants will receive the investigational device called the Bidirectional Neural Bypass System. The study intends to use this device to restore volitional movement and sensation to the hand and wrist of an individual during its use in the laboratory.

Study groups in NCT03680872
Study groupRoleWhat they receive
Spinal Cord Injury ParticipantsExperimentalThis group consists of individuals with tetraplegia receiving an investigational device called the Bidirectional Neural Bypass System.
Receives: Device: Bidirectional Neural Bypass System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Restoration of Movement

    The primary outcome of restoring movement will be evaluated through Graded Redefined Assessment of Strength, Sensibility \& Prehension. The performance will be graded on a numeric scale from 0-92, where a higher number indicates a better outcome.

    Participants will complete 10 distinct arm, wrist, and finger movements. The movements will be evaluated on a 5-point scale ranging from no movement to normal movement for a total of 0-50.

    Participants will be asked to perform a cylindrical grasp, key pinch, and a thumb-index pinch. The movements will be evaluated on a 4-point scale ranging from an inability to position wrist and fingers to able to perform movement with normal force for a total of 0-12.

    Participants will be asked to pour water, unscrew lids, place pegs on a board, open a lock, drop coins in a slot, and screw nuts. The movements will be evaluated on a 5-point scale ranging from 0% completed to 100% completed with expected grasp and no difficulties for a total of 0-30.

    Measured: The primary outcome will be assessed over the course of 48 months during the study's restoration sessions.

  2. Restoration of Sensation

    The primary outcome of restoring the perception of tactile sensation of the hand will be evaluated through the 5-Point Likert Scale. Participants will be asked whether they perceive sensation in response to objects being placed against the hand and fingertips. Participants will indicate whether they feel the object by selecting either strongly disagree (1), disagree (2), neutral (3), agree (4), or strongly agree (5). A higher total response score indicates an improvement in outcome.

    Measured: The primary outcome will be assessed over the course of 48 months during the study's restoration sessions.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2018
  2. Study start30 Sep 2019
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.
Masking
None (open label)
Enrolment
7 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03680872
Sponsor's protocol ID
17-0840
Status last verified
Jun 2025
First submitted
27 Aug 2018
Last updated
11 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Currently, there are no plans to make individual participant data available.

Publications

  • Bouton CE, Shaikhouni A, Annetta NV, Bockbrader MA, Friedenberg DA, Nielson DM, Sharma G, Sederberg PB, Glenn BC, Mysiw WJ, Morgan AG, Deogaonkar M, Rezai AR. Restoring cortical control of functional movement in a human with quadriplegia. Nature. 2016 May 12;533(7602):247-50. doi: 10.1038/nature17435. Epub 2016 Apr 13.

    PubMed 27074513
  • Sharma G, Friedenberg DA, Annetta N, Glenn B, Bockbrader M, Majstorovic C, Domas S, Mysiw WJ, Rezai A, Bouton C. Using an Artificial Neural Bypass to Restore Cortical Control of Rhythmic Movements in a Human with Quadriplegia. Sci Rep. 2016 Sep 23;6:33807. doi: 10.1038/srep33807.

    PubMed 27658585

Questions about this trial

What is this clinical trial studying?

A study testing Bidirectional Neural Bypass System in people with Spinal Cord Injuries and Spinal Cord Injury Cervical, run by Chad Bouton at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 32 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Erona Ibroci, MPH (516-562-3634, eibroci@northwell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Restoration of Movement (time frame: The primary outcome will be assessed over the course of 48 months during the study's restoration sessions.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03680872, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in